Cargando…
Antioxidant Therapeutics in Parkinson’s Disease: Current Challenges and Opportunities
Oxidative stress is considered one of the pathological mechanisms that cause Parkinson’s disease (PD), which has led to the investigation of several antioxidants molecules as a potential therapeutic treatment against the disease. Although preclinical studies have demonstrated the efficacy of these c...
Autores principales: | Duarte-Jurado, Ana Patricia, Gopar-Cuevas, Yareth, Saucedo-Cardenas, Odila, Loera-Arias, Maria de Jesus, Montes-de-Oca-Luna, Roberto, Garcia-Garcia, Aracely, Rodriguez-Rocha, Humberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998929/ https://www.ncbi.nlm.nih.gov/pubmed/33803945 http://dx.doi.org/10.3390/antiox10030453 |
Ejemplares similares
-
Phosphorylated α-Synuclein-Copper Complex Formation in the Pathogenesis of Parkinson's Disease
por: Castillo-Gonzalez, Juan Antonio, et al.
Publicado: (2017) -
Unscrambling the Role of Redox-Active Biometals in Dopaminergic Neuronal Death and Promising Metal Chelation-Based Therapy for Parkinson’s Disease
por: Gonzalez-Alcocer, Alfredo, et al.
Publicado: (2023) -
4-1BBL as a Mediator of Cross-Talk between Innate, Adaptive, and Regulatory Immunity against Cancer
por: Martinez-Perez, Alejandra G., et al.
Publicado: (2021) -
Plasmid DNA for Therapeutic Applications in Cancer
por: Martínez-Puente, David Hernán, et al.
Publicado: (2022) -
Hyaluronate Functionalized Multi-Wall Carbon Nanotubes Filled with Carboplatin as a Novel Drug Nanocarrier against Murine Lung Cancer Cells
por: Salas-Treviño, Daniel, et al.
Publicado: (2019)